{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:17:54Z","timestamp":1773011874052,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.leukres.2003.11.002","type":"journal-article","created":{"date-parts":[[2004,2,6]],"date-time":"2004-02-06T10:17:37Z","timestamp":1076062657000},"page":"595-604","source":"Crossref","is-referenced-by-count":53,"title":["Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin\u2019s lymphoma or Hodgkin\u2019s lymphoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Francis J","family":"Giles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Anh","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella M","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghi","family":"Manshouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Bociek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop M","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Albitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2003.11.002_BIB1","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.V96.10.3656","article-title":"Angiogenesis in acute myeloid leukemia","volume":"96","author":"Di Raimondo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000046614","article-title":"Angiogenesis in chronic myeloproliferative diseases","volume":"106","author":"Di Raimondo","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB3","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2141.2001.02690.x","article-title":"Angiogenesis in multiple myeloma","volume":"113","author":"Rajkumar","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB5","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s002770000236","article-title":"Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma","volume":"79","author":"Sezer","year":"2000","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB7","first-page":"23","article-title":"The emerging role of angiogenesis inhibitors in hematologic malignancies","volume":"16","author":"Giles","year":"2002","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.leukres.2003.11.002_BIB8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(00)00268-6","article-title":"Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family","volume":"49","author":"Zachary","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1634\/theoncologist.6-suppl_5-32","article-title":"The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies","volume":"6","author":"Giles","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.leukres.2003.11.002_BIB10","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.94.16.8761","article-title":"Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal","volume":"94","author":"Benjamin","year":"1997","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2003.11.002_BIB11","first-page":"800","article-title":"Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood","volume":"85","author":"Di Raimondo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2003.11.002_BIB12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.leu.2402124","article-title":"Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis","volume":"15","author":"Di Raimondo","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2003.11.002_BIB13","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1182\/blood.V94.11.3717","article-title":"Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia","volume":"94","author":"Aguayo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.10020","article-title":"Soluble angiogenic factors: implications for chronic myeloproliferative disorders","volume":"69","author":"Musolino","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2003.11.002_BIB16","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood.V96.10.3374","article-title":"Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia","volume":"96","author":"Mesa","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2141.1997.292671.x","article-title":"Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis","volume":"97","author":"Martyre","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1349-7006.2002.tb01278.x","article-title":"Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity","volume":"93","author":"Sato","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/152581602753448586","article-title":"Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia","volume":"11","author":"Brunner","year":"2002","journal-title":"J Hematother. Stem. Cell Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428190109097679","article-title":"Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia","volume":"42","author":"Yetgin","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2003.11.002_BIB21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.leu.2402182","article-title":"Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome","volume":"15","author":"Verstovsek","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2003.11.002_BIB22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.0007-1048.2002.03364.x","article-title":"Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma","volume":"116","author":"Iwasaki","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/10428199909167385","article-title":"The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies","volume":"32","author":"Borset","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2003.11.002_BIB24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000046613","article-title":"Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome","volume":"106","author":"Albitar","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000046615","article-title":"Angiogenesis in lymphoproliferative disorders","volume":"106","author":"Salven","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB26","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V90.8.3167","article-title":"A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin\u2019s lymphoma","volume":"90","author":"Salven","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2141.2001.02921.x","article-title":"Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome","volume":"114","author":"Verstovsek","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. Royal Stat. Soc."},{"key":"10.1016\/j.leukres.2003.11.002_BIB29","unstructured":"Cox DR, Oakes D. Analysis of Survival Data. Chapman and Hall, New York, 1984."},{"key":"10.1016\/j.leukres.2003.11.002_BIB30","unstructured":"The SAS System for Windows (ed Release 8.1). Cary, NC, SAS Institute Inc., 2000."},{"key":"10.1016\/j.leukres.2003.11.002_BIB31","unstructured":"Division DAP: S-PLUS 2000, (ed Professional Release 3). Seattle, WA, MathSoft Inc., 2000."},{"key":"10.1016\/j.leukres.2003.11.002_BIB32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF02982037","article-title":"Angiogenesis in hematologic malignancies and its clinical implications","volume":"75","author":"Yang","year":"2002","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB33","first-page":"4333","article-title":"Angiogenesis","volume":"21","author":"Ribatti","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00277-001-0398-3","article-title":"Angiogenesis in hematologic malignancies","volume":"80","author":"Moehler","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.1999.01547.x","article-title":"Angiogenic growth factors and endostatin in non-Hodgkin\u2019s lymphoma","volume":"106","author":"Bertolini","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB36","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1182\/blood.V94.10.3334.422k18_3334_3339","article-title":"A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin\u2019s lymphoma","volume":"94","author":"Salven","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB37","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1182\/blood.V96.12.3712","article-title":"Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients","volume":"96","author":"Salven","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-0037-1615158","article-title":"Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation","volume":"80","author":"Wartiovaara","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.leukres.2003.11.002_BIB39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9440(10)65550-2","article-title":"Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors","volume":"153","author":"Salven","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10428190290005964","article-title":"Angiogenic and lymphangiogenic molecules in hematological malignancies","volume":"43","author":"Orpana","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2003.11.002_BIB41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s000180050101","article-title":"Organogenesis and angiogenin","volume":"53","author":"Vallee","year":"1997","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.leukres.2003.11.002_BIB42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s000180050210","article-title":"The angiogenins","volume":"54","author":"Strydom","year":"1998","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.leukres.2003.11.002_BIB43","first-page":"345","article-title":"Angiogenin, a potent mediator of angiogenesis. Biological, biochemical and structural properties","volume":"47","author":"Badet","year":"1999","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.leukres.2003.11.002_BIB44","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1021\/bi00360a008","article-title":"Characteristic ribonucleolytic activity of human angiogenin","volume":"25","author":"Shapiro","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.leukres.2003.11.002_BIB45","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1021\/bi00419a013","article-title":"Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes","volume":"27","author":"St Clair","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.leukres.2003.11.002_BIB46","first-page":"703","article-title":"Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness","volume":"56","author":"Shimoyama","year":"19962","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB47","first-page":"2161","article-title":"Angiogenin expression and prognosis in primary breast carcinoma","volume":"4","author":"Montero","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB48","first-page":"1125","article-title":"Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression","volume":"5","author":"Shimoyama","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2003.11.002_BIB49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s004320000138","article-title":"Increased angiogenin expression in gastric cancer correlated with cancer progression","volume":"126","author":"Shimoyama","year":"2000","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.1151","article-title":"Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin\u2019s disease","volume":"197","author":"Doussis-Anagnostopoulou","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.leukres.2003.11.002_BIB51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V97.4.1063","article-title":"Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease","volume":"97","author":"Teofili","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.11.002_BIB52","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/annonc\/mdf228","article-title":"The International Prognostic Factors Project score for advanced Hodgkin\u2019s disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation","volume":"13","author":"Bierman","year":"2002","journal-title":"Ann. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:41:23Z","timestamp":1734255683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603003916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0145212603003916"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2003.11.002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}